IXICO plc - IXICO Supports the AD Neuroimaging Initiative
03 February 2020
("IXICO" or the "Company")
IXICO Supports the Alzheimer's Disease Neuroimaging Initiative
ADNI is a longitudinal multicentre study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimer's disease (AD). Its goals are to detect AD at the earliest stage possible (pre-dementia) and identify ways to track the disease's progression with biomarkers, as well as to support advances in AD intervention, prevention, and treatment through the application of new diagnostic methods in a pre-competitive environment and through data sharing to advance the field in AD.
The ADNI-PPSB, convened by the
For further information please contact:
| || |
+44 (0) 20 3763 7498
| || |
| || |
| || |
+44 (0) 203 950 9144
Mary Clark /
IXICO's purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience.
Our goal is to be a leading proponent in the use of Artificial Intelligence (AI) in clinical development, to improve biopharma R&D productivity through the adoption of breakthrough data analytics in precision healthcare. Through the deployment of novel AI algorithms, we analyse and interpret brain scans and digital biosensor data to enable better trial design, patient selection and ultimately clinical outcomes across all phases of clinical evaluation. Our data analytics services are deployed on some of the most important clinical trials in neuroscience, providing valuable insights to disease progression and patient safety, enabling our clients to make better informed decisions earlier in the clinical development pathway.
More information is available on www.IXICO.com
This information is provided by RNS, the news service of the
Quick facts: IXICO PLC
Market Cap: £29.01 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE